Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Doha Bank Q.P.S.C. Interim / Quarterly Report 2021

Apr 28, 2021

10819_10-q_2021-04-28_9810b63e-a15b-4e6d-a814-38cece13dfb8.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

Interim Condensed Consolidated Financial Statements

As at and for the three month period ended
31 March 2021

$\sim$

.,

$\left\langle \psi \right\rangle$

Interim condensed consolidated financial statements
As at and for the three month period ended 31 March 2021

Contents

Page(s)

Independent auditor's review report $\blacktriangleleft$
Interim consolidated statement of financial position 2
Interim consolidated income statement 3
Interim consolidated statement of comprehensive income $\overline{a}$
interim consolidated statement of changes in equity -5
Interim consolidated statement of cash flows 6
Notes to the interim condensed consolidated financial statements 7-18

KPMG 25 C Ring Road PO Box 4473. Doha State of Qatar Telephone: +974 4457 6444 Fax: +974 4442 5626 Website: home.kpmg/ga

Independent auditor's report on review of interim condensed consolidated financial statements to the Board of Directors of Doha Bank Q.P.S.C.

Introduction

We have reviewed the accompanying 31 March 2021 interim condensed consolidated financial statements of Doha Bank Q.P.S.C. (the 'Bank') and its subsidiaries (together the 'Group'), which comprise:

  • the interim consolidated statement of financial position as at 31 March 2021;
  • the interim consolidated income statement for the three month period ended 31 March 2021:
  • the interim consolidated statement of comprehensive income for the three month period ended 31 March 2021;
  • the interim consolidated statement of changes in equity for the three month period ended 31 March 2021;
  • the interim consolidated statement of cash flows for the three month period ended 31 March 2021; and
  • notes to the interim condensed consolidated financial statements.

The Board of Directors of the Bank is responsible for the preparation and presentation of these condensed consolidated interim financial statements in accordance with International Accounting Standard 34, 'Interim Financial Reporting' ('IAS 34') and applicable provisions of the Qatar Central Bank regulations. Our responsibility is to express a conclusion on these condensed consolidated interim financial statements based on our review.

Scope of Review

We conducted our review in accordance with the International Standard on Review Engagements 2410, 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity'. A review of interim financial statements consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

Conclusion

Based on our review, nothing has come to our attention that causes us to believe that the accompanying 31 March 2021 interim condensed consolidated financial statements are not prepared, in all material respects, in accordance with IAS 34 and applicable provisions of the Qatar Central Bank regulations.

28 April 2021 Doha State of Qatar

Gopal Balasubramaniam KPMG

Qatar Auditor's Registry Number 251 Licensed by QFMA: External Auditor's License No. 120153

KPMG, Qatar Branch is registered with the Ministry of Economy and Commerce. State of Qatar as a member firm of the KPMG network of independent member firms affiliated with KPMG International
Cooperative ("KPMG International"), a Swiss entity.

Interim consolidated statement of financial position As at 31 March 2021

QAR '000s

Notes 31 March
2021
31 March
2020
31 December
2020
Reviewed Reviewed Audited
Assets
Cash and balances with central banks 6,345,470 5,520,315 6,895,185
Due from banks 8,773,699 7,213,703 3,673,577
Loans and advances to customers 7 70,532,759 65,324,326 65,450,036
Investment securities 8 24,033,528 25,192,105 24,667,333
Investment in an associate 10,160 9,887 10,176
Property, furniture and equipment 9 707,974 706,771 685,756
Other assets 1,743,577 2,449,854 2,158,209
Total assets 112, 147, 167 106,416,961 103,540,272
Liabilities
Due to banks 21,861,784 27, 159, 118 23,036,764
Customer deposits 63,672,216 54,798,944 55,053,996
Debt securities 10 2,135,513 472,827 328,208
Other borrowings 11 8,514,515 7,361,740 8,217,193
Other liabilities 2,005,284 4,482,350 3,109,541
Total liabilities 98,189,312 94,274,979 89,745,702
Equity
Share capital 12 3,100,467 3,100,467 3,100,467
Legal reserve 5,094,574 5,092,948 5,094,574
Risk reserve 849,600 849,600 849,600
Fair value reserve 168,920 (1, 335, 870) 152,992
Foreign currency translation reserve (62, 882) (67, 956) (62, 587)
Retained earnings 807,176 502,793 659,524
Total equity attributable to shareholders
of the Bank
9,957,855 8,141,982 9,794,570
Instruments eligible as additional Tier 1 capital 13 4,000,000 4,000,000 4,000,000
Total equity 13,957,855 12,141,982 13,794,570
Total liabilities and equity 112, 147, 167 106,416,961 103,540,272

The interim condensed consolidated financial statements were approved by the Board of Directors on 28 April 2021 and were signed on its behalf by:

Fahad Bin Mohammad Bin Jabor Al Thani Chairman

Abdul Rahman Bin Mohammad Bin Jabor Al Thani Managing Director

Dr. Raghavan Seetharaman Group Chief Executive Officer

The attached notes 1 to 21 form an integral part of these interim condensed consolidated financial statements,

Interim consolidated income statement For the three month period ended 31 March 2021

QAR '000s

Three month period ended
31 March 31 March
Note 2021 2020
Reviewed Reviewed
Interest income 898,027 1,030,890
Interest expense (236, 673) (482, 903)
Net interest income 661,354 547,987
Fee and commission income 110,359 121,970
Fee and commission expense (37, 248) (32,080)
Net fee and commission income 73,111 89,890
Gross written premium 11,593 13,098
Premium ceded (1, 598) (2,870)
Net claims paid (9,609) (6,085)
Net income from insurance activities 386 4,143
Net foreign exchange gain 41,115 27,949
Income from investment securities 31,854 70,090
Other operating income 15,542 4,889
88,511 102,928
Net operating income 823,362 744,948
Staff costs (113, 721) (116, 312)
Depreciation (26, 454) (29, 514)
Net impairment reversal on investment securities 4,406 2
Net impairment loss on loans and advances to customers (230, 571) (175, 709)
Net impairment reversal / (loss) on other financial assets 3,304 (13, 748)
Other expenses (78, 355) (85, 130)
Profit before tax (441, 391) (420, 411)
Income tax expense 381,971
(1,784)
324,537
Profit 380,187 (446)
324,091
Earnings per share
Basic and diluted earnings per share (QAR per share)
15
0.12 0.10

The attached notes 1 to 21 form an integral part of these interim condensed consolidated financial statements.

Interim consolidated statement of comprehensive income
For the three month period ended 31 March 2021

QAR '000s

Three month period ended
31 March 31 March
Note 2021 2020
Reviewed Reviewed
Profit 380,187 324,091
Other comprehensive income
Items that are or may be subsequently reclassified to
income statement:
Foreign currency translation differences for foreign operations (295) (9, 110)
Movement in fair value reserve (debt instruments – IFRS 9):
Net change in fair value (322, 892) (651, 970)
Net amount transferred to consolidated statement of income 324,198 (741,323)
1,011 (1, 402, 403)
Items that will not be reclassified subsequently to
statement of income
Net change in fair value of equity investments designated at
FVOCI (IFRS 9) 14,622 (97,620)
Other comprehensive income / (loss) 15,633 (1,500,023)
Total comprehensive income / (loss) 395,820 (1, 175, 932)

The attached notes 1 to 21 form an integral part of these interim condensed consolidated financial statements.

Interim consolidated statement of changes in equity
For the three month period ended 31 March 2021

2000 RAD

$\bar{\nu}$

Equity attributable to shareholders of the Bank
Share Legal Risk Fair value Foreign
currency
translation
Retained Total Instrument
eligible
as additional
Tier 1
capital Reserve reserve reserve reserve earnings capital Total equity
Balance at 1 January 2021 (Audited)
Total comprehensive income:
3,100,467 5,094,574 849,600 152,992 (62, 587) 659,524 9,794,570 4,000,000 13,794,570
Profit 380,187 380,187 380,187
Other comprehensive income / (loss) 15,928 (295) 15,633 15,633
Total comprehensive income / (loss)
Transactions with shareholders:
15,928 (295) 380,187 395,820 395,820
Balance at 31 March 2021
Dividends paid (Note 14)
(232, 535) (232, 535) (232, 535)
(Reviewed) 3,100,467 5,094,574 849,600 168,920 (62, 882) 807,176 9,957,855 4,000,000 13,957,855
Balance at 1 January 2020 (Audited)
Total comprehensive income:
3,100,467 5,092,948 849,600 155,043 (58, 846) 178,702 9,317,914 4,000,000 13,317,914
Profit 324,091 324,091 324,091
Other comprehensive loss (1,490,913) (9, 110) 1,500,023) (1,500,023)
Total comprehensive (loss) / income ï (1,490,913) (9, 110) 324,091 (1, 175, 932) (1, 175, 932)
Transactions with shareholders:
Dividends paid (Note 14)
Balance at 31 March 2020 (Reviewed) 3,100,467 5,092,948 849,600 (1,335,870) (67, 956) 502,793 8.141.982 4,000,000 12,141,982

The attached notes 1 to 21 form an integral part of these interim condensed consolidated inancial statements.

$\bar{\alpha}$

Interim consolidated statement of cash flows For the three month period ended 31 March 2021

QAR '000s

Three month period ended Year ended
31 March 31 March 31 December
2021 2020 2020
Note Reviewed Reviewed Audited
Cash flows from operating activities
Profit before tax 381,971 324,537 704,293
Adjustments for:
Net impairment loss on loans and advances to
customers 230,571 175,709 1,368,742
Net impairment (reversal) / loss on investment securities (4, 406) (2) 34,680
Net impairment (reversal) / loss on other financial
instruments (3, 304) 13,748 (38, 299)
Depreciation 26,454 29,514 117,290
Amortisation of financing cost 5,107 3,707 24,995
Net income from investment securities (21, 869) (57, 243) (155, 471)
Loss / (profit) on sale of property, furniture and
equipment 171 (26) 171
Share of results of an associate 50
Profit before changes in operating assets and
liabilities 614,695 489,944 2,056,451
Change in due from banks 1,311,524
Change in loans and advances to customers (1,000,829)
(5,329,419)
(1,012,971) 2,795,095
(3, 283, 569)
Change in other assets 414,632 (881, 135) (589, 490)
Change in due to banks (1, 174, 980) 3,122,170 (1,000,184)
Change in customer deposits 8,618,220 (3,664,889) (3,409,837)
Change in other liabilities (914, 545) 933,759 277,281
Social and sports fund contribution (17, 576) (18, 848) (18, 848)
Income tax expense (1, 560)
Net cash from / (used in) operating activities 1,210,198 279,554 (3, 174, 661)
Cash flows from investing activities
Acquisition of investment securities (545, 621) (2,486,316) (5,064,170)
Proceeds from sale of investment securities 1,221,645 2,421,719 7,076,464
Net acquisition of property, furniture and equipment (633) (12,688) (19, 879)
Proceeds from sale of property, furniture and equipment 4 26 17
Net cash from / (used in) in investing activities 675,395 (77, 259) 1,992,432
Cash flows from financing activities
Proceeds from other borrowings 297,322 502,691 1,358,144
Proceeds from / (repayment of) debt securities 1,802,198 (232) (169, 846)
Distribution on Tier 1 capital notes (203,000) (220,000) (203,000)
Dividends paid (232, 535)
Net cash from financing activities 1,663,985 282,459 985,298
Net increase / (decrease) in cash and cash
equivalents 3,549,578 484,754 (196, 931)
Cash and cash equivalents at the beginning of the
period/year 7,001,746 7,198,677 7,198,677
Cash and cash equivalents at the end of the period /
year 17 10,551,324 7,683,431 7,001,746
Operational cash flows from interest and dividend:
Interest received 878,081 1,038,729 3,753,833
Interest paid 283,922 526,316 1,642,954
Dividends received 9,985 12,847 28,206

The attached notes 1 to 21 form an integral part of these interim condensed consolidated financial statements.

Notes to the interim condensed consolidated financial statements As at and for the three month period ended 31 March 2021

$\mathbf{1}$ Reporting entity

Doha Bank Q.P.S.C. ("Doha Bank" or the "Bank") is an entity domiciled in the State of Qatar and was incorporated on 15 March 1979 as a Joint Stock Company under Emiri Decree No. 51 of 1978. The commercial registration of the Bank is 7115. The address of the Bank's registered office is Doha Bank Tower, Corniche Street, West Bay, P.O. Box 3818, Doha Qatar,

Doha Bank is engaged in conventional banking activities and operates through its head office in Qatar (Doha) and has 24 local branches, six overseas branches in the United Arab Emirates (Dubai & Abu Dhabi). State of Kuwait, the Republic of India (one branch each in Mumbai, Kochi and Chennai) and representative offices in United Kingdom, Singapore, Turkey, China, Japan, South Korea, Germany, Australia, Hong Kong, Canada, Bangladesh, South Africa, Sri Lanka and Nepal. The interim condensed consolidated financial statements for the three month period ended 31 March 2021 comprises of the Bank and its subsidiaries (together referred to as "the Group").

The principal subsidiaries of the Group are as follows:

Percentage of ownership
Country of Company's Company's 31 March 31 March
Company's name incorporation capital Activities 2021 2020
Sharq Insurance L.L.C. Qatar 100,000 General 100% 100%
Insurance
Doha Finance Limited Cayman 182 Debt 100% 100%
Island Issuance
DB Securities Limited Cayman 182 Derivatives 100% 100%
Island Transactions

$2.$ Basis of preparation

Statement of compliance $(a)$

The interim condensed consolidated financial statements have been prepared in accordance with IAS 34, Interim Financial Reporting and the applicable provisions of the Qatar Central Bank ("QCB") regulations.

The interim condensed consolidated financial statements do not include all the information and disclosures required in the annual financial statements and should be read in conjunction with the Group's annual consolidated financial statements as at and for the year ended 31 December 2020. The results for the three month perid ended 31 March 2021 are not necessarily indicative of the results that may be expected for the financial year ending 31 December 2021.

Estimates and judgements $(b)$

The preparation of the interim condensed consolidated financial statements in conformity with IFRS® Standards ("IFRS Standards") and QCB regulations requires management to make judgements, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these estimates.

In preparing the interim condensed consolidated financial information, significant judgements made by management in applying the Group's accounting policies and the key sources of estimation uncertainty were the same as those that were applied to the consolidated financial statements as at and for the year ended 31 December 2020.

Financial risk management $(c)$

The Group's financial risk management objectives and policies are consistent with those disclosed in the consolidated financial statements as at and for the year ended 31 December 2020.

Notes to the interim condensed consolidated financial statements As at and for the three month period ended 31 March 2021

$3.$ Significant accounting policies

The accounting policies and methods of computation adopted in the preparation of the interim condensed consolidated financial statements are the same as those followed in the preparation of the Group's consolidated financial statements as at and for the year ended 31 December 2020, except as noted below:

During the period, the following IFRS Standards and amendments to IFRS Standards have been applied by the Group in preparation of these interim condensed consolidated financial statements. The adoption of the below IFRS Standards and amendments to IFRS Standards did not result in changes to previously reported net profit or equity of the Group.

$a)$ New IFRS Standards adopted by the Group

Interest Rate Benchmark Reform - Phase 2, amendments to IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16 (Effective on 1 January 2021)

Interest Rate Benchmark Reform - Phase 2 amendments

Effective from 1 January 2021, the Group has implemented Interest Rate Benchmark Reform - Phase 2 amendments which address issues that might affect financial reporting as a result of the reform of an interest rate benchmark, including the effects of changes to contractual cash flows or hedging relationships arising from the replacement of an interest rate benchmark with an alternative benchmark rate. The amendments provide practical relief from certain requirements in IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16 relating to changes in the basis for determining contractual cash flows of financial assets, financial liabilities and lease liabilities and hedge accounting.

The amendments require an entity to account for a change in the basis for determining the contractual cash flows of a financial asset or financial liability that is required by interest rate benchmark reform by updating the effective interest rate of the financial asset or financial liability. In addition it provides certain exceptions to hedge accounting requirements.

The Group is in discussion with counterparties in relation to exposure to cash flow and fair value hedges and non-derivative financial assets and liabilities linked to Inter Bank Offered Rate maturing beyond the year 2021. Management is running a project on the Group's transition activities and preparedness for adopting alternate reference rates and continues to engage with various stakeholders to support an orderly transition and to mitigate the risks resulting from the transition.

$\mathbf{b}$ IFRS Standards and amendments issued but not yet effective

  • $\bullet$ Onerous Contracts - Cost of Fulfilling a Contract - Amendments to IAS 37 (Effective on 1 January 2022)
  • Property, Plant and Equipment: Proceeds before Intended Use Amendments to IAS 16 (Effective on 1 January 2022)
  • Reference to the Conceptual Framework Amendments to IFRS 3 (Effective on 1 January 2022)
  • Annual Improvements to IFRS Standards 2018 2020 (Effective on 1 January 2022)
  • Classification of Liabilities as Current or Non-current Amendments to IAS 1 (Effective on 1 January 2023)
  • IFRS 17 "Insurance Contracts" (Effective on 1 January 2023)

The Group is currently evaluating the impact of these new IFRS Standards. The Group will adopt these new IFRS Standards on their effective dates.

Notes to the interim condensed consolidated financial statements As at and for the three month period ended 31 March 2021

QAR '000s

$\overline{4}$ . Financial Risk Management

The Group's financial risk management objectives and policies are consistent with those disclosed in the consolidated financial statements as at and for the year ended 31 December 2020.

Exposure and related ECL movements $(a)$

31 March 2021
(Reviewed)
31 March
2020
(Reviewed)
Stage 1 Stage 2 Stage 3 Total Total
Gross exposures subject to ECL - as at
31 March
- Loans and advances to customers 50,608,508 19,337,874 4,205,784 74, 152, 166 70,176,263
- Investment securities (debt) 23,008,789 298,698 17.032 23,324,519 24,682.217
- Loan commitments and financial guarantees 12,296,628 4,081,274 753,627 17, 131, 529 19,311,309
- Due from banks and balances with central Banks 12,486,281 1,958,900 $\blacksquare$ 14,445,181 12,052,735
98,400,206 25,676,746 4,976,443 129,053,395 126,222,524
Opening balance of ECL / impairment - as at
1 January
- Loans and advances to customers* 138,241 988,162 2,221,405 3,347,808 5,129,571
- Investment securities (debt) 8,904 42,433 6,474 57,811 41,724
- Loan commitments and financial guarantees 15,125 22,226 171,307 208,658 244,286
- Due from banks and balances with central Banks 1,704 310 2,014 8,518
163.974 1,053,131 2,399,186 3,616,291 5,424,099
Net charge and transfers for the period (net of
foreign currency translation)
- Loans and advances to customers* (10, 652) 18,247 457,183 464,778 276,064
- Investment securities (debt) (275) (4, 131) (4, 406) (2)
- Loan commitments and financial quarantees (1,069) (5,864) (6,933) 9,964
- Due from banks and balances with central Banks 986 2,643 3,629 (120)
(11,010) 10,895 457,183 457,068 285,906
Write offs and other during the period
- Loans and advances to customers* (193, 179) (193, 179) (553, 698)
- Investment securities (debt)
- Loan commitments and financial guarantees 11,287 11,287
- Due from banks and balances with central Banks
Closing balance of ECL / impairment - as at
31 March
(181, 892) (181, 892) (553, 698)
- Loans and advances to customers* 127,589 1,006,409 2,485,409 3,619,407 4,851,937
- Investment securities (debt) 8,629 38,302 6,474 53,405 41,722
- Loan commitments and financial guarantees 14,056 16,362 182,594 213,012 254,250
- Due from banks and balances with central Banks 2,690 2,953 5,643 8,398
152,964 1,064,026 2,674,477 3,891,467 5,156,307

* stage 3 provision includes interest in suspense

Operating segments
ທ່
QAR '000s
The Group organizes and manages its operations by 2 business segments, which comprise conventional banking and insurance activities.
Conventional Banking
deposits to corporate customers. It also undertakes funding and centralized risk management activities through borrowings, issue of debt securities, use of
Corporate Banking provides a range of product and service offerings to business and corporate customers including funded and non-funded credit facilitates and
Retail Banking provides a diversified range of products and services to individuals. The range includes loans, credit cards, deposits and other transactions with
derivatives for risk management purposes and investing in liquid assets such as short term placements and corporate and government debt securities.
retail customers.
Insurance activities to customers include effecting contracts of insurance, carrying out contracts of insurance, arranging deals in investments and advising on
Insurance Activities
investments.
Details of each segment as of and for the three month period ended 31 March 2021 and 31 March 2020 are stated below;
For the three month period ended 31 March 2021 Conventional Banking
Corporate
Banking
Banking
Retail
Unallocated Total Insurance Total
Net interest income 624,288 37,066 661,354 661,354
Net income on insurance activities 386 386
Net other operating income 106,369 40,003 15,542 161,914 (292) 161,622
Segmental revenue 730,657 77,069 15,542 823,268 $\mathfrak{B}$ 823,362
Net impairment loss on loans and advances to
Total expense
(214, 705) (2,305) (217,010)
customers (230, 571) (230, 571)
Impairment reversal on investment securities 4,406 4,406
Net profit 382,398 (2,211) 380,187
As at 31 March 2021
Assets 98,006,294 5,145,504 8,797,021 111,948,819 188,188 112, 137, 007
Investment in an associate 10.160
Total assets 112, 147, 167
Liabilities 85,749,222 11,249,016 1,105,409 98,103,647 85,665 98,189,312
Contingent items 17,063,467 68,062 17,131,529 17,131,529

ž, Ļ 5,

$-01$

$\overline{\phantom{a}}$

QAR '000s

Doha Bank Q.P.S.C.

Notes to the interim condensed consolidated financial statements
As at and for the three month period ended 31 March 2021

Operating segments (continued) $\dot{\mathbf{v}}$

For the three month period ended 31 March 2020

For the three month period ended 31 March 2020 Conventional Banking
Corporate Retail
Banking Banking Unallocated Total Insurance Total
Net interest income 489,027 58,960 547,987 547,987
Net income on insurance activities 4,143 4,143
Net other operating income 150,255 37,230 4,889 192,374 444 192,818
Segmental revenue 639,282 96,190 4,889 740,361 4,587 744,948
Total expense (243, 057) (2,093) (245, 150)
Net impairment loss on loans and advances to
customers
(175, 709) (175, 709)
Impairment loss on investment securities $\mathbf{\Omega}$
Net profit 321,597 2,494 324,091
As at 31 December 2020
Assets 88,525,339 5,064,422 9,739,150 103,328,911 201,185 103,530,096
Investment in an associate 10,176
Total assets 103,540,272
Liabilities 76,652,730 10,762,410 2,234,526 89,649,666 96,036 89,745,702
Contingent items 17,090,189 66,604 17,156,793 17,156,793

$\overline{1}$

ò,

$\bar{\chi}$

Notes to the interim condensed consolidated financial statements As at and for the three month period ended 31 March 2021

QAR '000s

6. Fair value of financial instruments

Fair value hierarchy

All financial instruments for which fair value is recognised or disclosed are categorised within the fair value hierarchy, described as follows, based on the lowest level input that is significant to the fair value measurement as a whole:

Level 1 - Quoted market prices in an active market (that are unadjusted) for identical assets or liabilities

Level 2 - Valuation techniques for which the lowest level input that is significant to the fair value measurement is directly or indirectly observable

Level 3 - Valuation techniques for which the lowest level input that is significant to the fair value measurement is unobservable

For financial instruments that are recognised at fair value on a recurring basis, the Group determines whether transfers have occurred between Levels in the hierarchy by re-assessing categorisation (based on the lowest level input that is significant to the fair value measurement as a whole) at the end of each reporting period.

As at 31 March 2021, the Group held the following classes of financial instruments measured at fair value:

Level 1 Level 2 Level 3 Total
At 31 March 2021
Financial assets measured at fair value:
Investment securities measured at FVOCI 10,847,291 4,848,510 50,445 15,746,246
Investment securities measured at FVTPL 46,897 35,193 82,090
Derivative instruments:
Interest rate swaps 60,898 60,898
Forward foreign exchange contracts 15,075 15,075
10,894,188 4,924,483 85,638 15,904,309
Financial liabilities measured at fair value:
Derivative instruments:
Interest rate swaps 536,503 536,503
Forward foreign exchange contracts 30,919 30,919
567,422 567,422
Level 1 Level 2 Level 3 Total
At 31 December 2020
Financial assets measured at fair value:
Investment securities measured at FVOCI 11,513,998 4,848,510 51,046 16,413,554
Investment securities measured at FVTPL 20,239 34,940 55,179
Derivative instruments:
Interest rate swaps 57,700 57,700
Forward foreign exchange contracts 92,466 92,466
11,534,237 4,998,676 85,986 16,618,899
Financial liabilities measured at fair value:
Derivative instruments:
Interest rate swaps 894,928 894,928
Forward foreign exchange contracts 15,058 15,058
909,986 909,986

During the reporting period ended 31 March 2021, there were no transfers between Level 1, Level 2 and Level 3 fair value measurements.

Notes to the interim condensed consolidated financial statements As at and for the three month period ended 31 March 2021

QAR '000s

6. Fair value of financial instruments (continued)

Valuation techniques

Fair values of financial assets and financial liabilities that are traded in active markets are based on quoted market prices or dealer price quotations. For all other financial instruments the Group determines fair values using valuation techniques.

Valuation techniques include net present value and discounted cash flow models, comparison to similar instruments for which market observable prices exist. Assumptions and inputs used in valuation techniques include risk-free and benchmark interest rates, credit spreads and other premium used in estimating discount rates, bond and equity prices, foreign currency exchange rates, equity and equity index prices and expected price volatilities and correlations. The objective of valuation techniques is to arrive at a fair value determination that reflects the price of the financial instrument at the reporting date that would have been determined by market participants acting at arm's length.

The foreign currency forward contracts are measured based on observable spot exchange rates, the yield curves of the respective currencies as well as the currency basis spreads between the respective currencies. All contracts are fully cash collateralised, thereby eliminating both counterparty and the Group's own credit risk.

7. Loans and advances to customers

31 March
2021
31-March
2020
31 December
2020
Reviewed Reviewed Audited
Loans 54,680,154 57.382.732 54,462,315
Overdrafts 18,872,222 11,189,543 13,595,830
Bills discounted 139,998 334,060 190,370
Other* 464,514 1,280,320 554,021
74,156,888 70,186,655 68,802,536
Deferred profit (4, 722) (10, 392) (4,692)
ECL on loans and advances to customers (stage 1 & 2)
Net impairment on loans and advances to customers
(1, 133, 998) (1,649,245) (1, 126, 403)
(Stage 3) (2,485,409) (3,202,692) (2,221,405)
Net loans and advances to customers* 70,532,759 65,324,326 65,450,036

The aggregate amount of non-performing loans and advances to customers at 31 March 2021 amounted to QAR 4,206 million which represents 5.67% of total loans and advances to customers (31 March 2020: QAR 3,995 million, 5.69% of total loans and advances to customers; 31 December 2020: QAR 4,115 million, 5.98% of total loans and advances to customers).

During the period, the Group has written off fully provided non-performing loans amounting to QAR 182 million (31 March 2020: QAR 554 million, 31 December 2020: QAR 3,978 million) as per Qatar Central Bank circular no. 68/2011.

Net impairment of loans and advances includes QAR 879 million of interest in suspense (31 March 2020; QAR 925 million; 31 December 2020: QAR 797 million).

*This includes acceptances pertaining to trade finance activities amounting to QAR 142 million (31 March 2020: QAR 1,110 million; 31 December 2020: QAR 158 million).

The net impairment loss on loans and advances to customers in the income statement includes QAR 94.6 million recovery from the loans & advances previously written off for the period ended 31 March 2021 (31 March 2020: QAR 4.3 million).

Notes to the interim condensed consolidated financial statements As at and for the three month period ended 31 March 2021

QAR '000s

$\mathbf{8}$ . Investment securities

31 March
2021
Reviewed
31 March
2020
Reviewed
31 December
2020
Audited
Investment securities measured at FVOCI 15,590,186 16,139,176 16,268,922
Investment securities measured at FVTPL 82,090 71,109 55,179
Investment securities measured at amortised cost 8.137.852 8,762,137 8,141,932
Interest receivable 230.303 245,037 208,220
24,040,431 25,217,459 24,674,253
Net impairment losses on investment securities (6,903) (25, 354) (6,920)
24,033,528 25,192,105 24,667,333

The Group has pledged State of Qatar Bonds bonds amounting to QAR 7,125 million as at 31 March 2021 (31 March 2020: QAR 9,848 million; 31 December 2020: QAR 8,900 million) against repurchase agreements.

9. Property, furniture and equipment

Acquisitions and disposals

During the period ended 31 March 2021, the Group acquired assets with a cost of QAR 0.6 million (31 March 2020: QAR 4.2 million; 31 December 2020: QAR 20 million).

Asset disposals made by the Group during the period ended 31 March 2021 amounted to QAR 1.5 million (31 March 2020: QAR 1.5 million, 31 December 2020: QAR 2.2 million), at original cost.

10. Debt securities

$(7) - 0.7$ COLLANS 31 March
2021
31 March
2020
31 December
2020
Reviewed Reviewed Audited
Senior guaranteed notes 2,133,777 471.831 327,430
Interest payable 1.736 996 778
2,135,513 472,827 328,208

Note:

The Group has issued USD 563 million and JPY 3.0 billion as at 31 March 2021 (31 March 2020: USD 55 million and JPY 8.1 billion; 31 December 2020: USD 63 million and JPY 3.0 billion) senior unsecured debt under its updated EMTN programme.

Notes to the interim condensed consolidated financial statements As at and for the three month period ended 31 March 2021

11. Other borrowings

31 March 31 March 31 December
2021 2020 2020
Reviewed Reviewed Audited
Term loan facilities 8,501,700 7,325,150 8,200,026
Interest payable 12,815 36,590 17.167
8,514,515 7,361,740 8,217,193

QAR '000s

The table below shows the maturity profile of other borrowings:

31 March
2021
31 March
2020
31 December
2020
Reviewed Reviewed Audited
Upto 1 year 3,362,685 5,075,565 5,806,659
Between 1 and 3 years 5,151,830 2,286,175 2,410,534
8,514,515 7,361,740 8,217,193
12.
Share capital
31 March
2021
31 March
2020
31 December
2020
Reviewed Reviewed Audited
Authorised number of
ordinary shares (in thousands) 3,100,467 3,100,467 3,100,467
(Nominal value of ordinary shares QAR 1 each)
Issued and paid up capital (in thousands of Qatar Rivals) 3,100,467 3,100,467 3,100,467

All shares are of the same class and carry equal voting rights.

$13.$ Instrument eligible as additional tier 1 capital

31 March
2021
Reviewed
31 March
2020
Reviewed
31 December
2020
Audited
Issued on 31 December 2013 2,000,000 2.000.000 2,000,000
Issued on 30 June 2015 2,000,000 2,000,000 2,000,000
4,000,000 4,000,000 4,000,000

The Group has issued regulatory Tier I capital notes totaling to QAR 4 billion. These notes are perpetual, subordinated, unsecured and each has been priced at a fixed interest rate for the first six years and shall be re-priced thereafter. The coupon is discretionary and the event on non-payment is not considered as an event of default. The notes carry no maturity date and have been classified under Tier 1 capital.

14. Dividend

The Board of Directors' proposal of a 7.5% cash dividend amounting to QAR 233 million for the year ended 31 December 2020 (2019: Nil), was approved at the Annual General Assembly held on 15 March 2021.

Notes to the interim condensed consolidated financial statements As at and for the three month period ended 31 March 2021

QAR '000s

$15.$ Earnings per share

31 March
2021
31 March
2020
Reviewed Reviewed
Basic and diluted
Profit attributable to the shareholders of the Bank 380,187 324,091
Weighted average number of outstanding ordinary shares in thousands 3,100,467 3.100,467
Basic and diluted earnings per share (QAR) 0.12 0.10

16. Financial commitments and contingencies

31 March
2021
31 March
2020
31 December
2020
Reviewed Reviewed Audited
Contingent commitments
(a)
Guarantees 12,130,224 12,920,882 12,392,098
Letter of credit 4,385,904 4,472,731 3,670,942
Unused credit facilities 615,401 1,917,696 1,093,753
Others 61,715 50,720 59,694
17,193,244 19,362,029 17,216,487
(b) Other commitments
Derivative financial instruments:
Forward foreign exchange contracts 6,429,443 10,097,921 9.604.548
Interest rate swaps 6,697,417 7,270,433 6.604.533
13,126,860 17,368,354 16,209,081
Total 30,320,104 36,730,383 33,425,568

The derivative instruments are reflected at their fair value and are presented under other commitments at their notional amount.

17. Cash and cash equivalents

31 March
2021
Reviewed
31 March
2020
Reviewed
31 December
2020
Audited
Cash and balances with central banks * 3,978,833 3.224.404 4,755,276
Due from banks up to 90 days 6.572.491 4,459,027 2.246.470
10,551,324 7,683,431 7,001,746

* Cash and balances with central banks do not include the mandatory cash reserve.

Notes to the interim condensed consolidated financial statements As at and for the three month period ended 31 March 2021

QAR '000s

18. Related party transactions

The Group enters into transactions, arrangements and agreements involving member of the Board of Directors and their related concern in the ordinary course of business at commercial interest and commission rates. The balances with related parties and transactions with related parties at the end of the reporting period were as were as follows:

31 March
2021
31 March
2020
31 December
2020
Reviewed Reviewed Audited
Statement of financial postion items
Loans, advances and financing activities 1,793,587 1,808,866 1,824,272
Deposits 555,485 714,245 669,281
Contingent liabilities and other commitments 570,217 647,165 600,477
Others assets 8,305 8,305 8,305
31 March
2021
31 March
2020
Reviewed Reviewed
Statement of income and expenses items
Interest and fee income 13,631 10,750
Interest, fee and commission expenses 5,775 7,876
Compensation to Board of Directors
Salaries and other benefits 8,864 9,005
End of service benfits and pension fund 406
8,864 9,411
  1. Capital adequacy
31 March
2021
31 March
2020
31 December
2020
Reviewed Reviewed Audited
Common Equity Tier 1 Capital 9,395,083 7.647.418 9.379.037
Additional Tier 1 Capital 4,000,000 4,000,000 4,000,000
Additional Tier 2 Capital 834,604 906,159 825,583
Total Eligible Capital 14,229,687 12,553,577 14,204,620
Risk Weighted Assets 72,274,803 77,727,540 71,908,257
Total Capital Ratio 19.69% 16.15% 19.75%

The minimum total Capital Adequacy Ratio requirements under Basel III as per QCB Requirements is as follows:

Minimum limit without Capital Conservation buffer is 10%; and

Minimum limit including Capital Conservation buffer, ICAAP buffer and the applicable Domestic Systemically Important Bank ("DSIB") buffer is 12.5%.

20. Impact of COVID-19

The coronavirus ("COVID-19") pandemic has spread across various geographies globally, causing disruption to business and economic activities. COVID-19 has brought about uncertainties in the global economic environment. The fiscal and monetary authorities, both domestic and international, have announced various support measures across the globe to counter possible adverse implications.

Notes to the interim condensed consolidated financial statements As at and for the three month period ended 31 March 2021

20. Impact of COVID-19 (continued)

The Bank is closely monitoring the situation and has activated its business continuity planning and other risk management practices to manage the potential business disruption the COVID-19 outbreak may have on its operations and financial performance.

$(a)$ Expected credit losses

The uncertainties caused by COVID-19, and the volatility in oil prices have required the Bank to update the inputs and assumptions used for the determination of expected credit losses ("ECLs"). ECLs were estimated based on a range of forecast economic conditions as at that date and considering that the situation is fast evolving, the Bank has considered the impact of higher volatility in the forward-looking macro-economic factors, when determining the severity and likelihood of economic scenarios for ECL determination.

$(b)$ Valuation estimates and judgements

The Bank has considered potential impacts of the current economic volatility in determination of the reported amounts of the Bank's financial and non-financial assets and these are considered to represent management's best assessment based on observable information. Markets however remain volatile and the recorded amounts remain sensitive to market fluctuations.

The impact of such uncertain economic environment is judgmental and the Bank will continue to reassess its position and the related impact on a regular basis.

As with any economic forecasts, the projections and likelihoods of the occurrence are subject to a high degree of inherent uncertainty and therefore the actual outcomes may be significantly different to those projected.

Accounting for modified loans and advances $(c)$

As part of QCB support program, the Bank has deferred payments on lending facilities for those companies that qualify as affected sectors. The payment reliefs are considered as short-term liquidity support to address the borrowers' potential cash flow issues. The Bank has effected the payment reliefs by deferring the installments with no additional costs to be borne by the customer. The accounting impact of these changes in terms of the credit facilities has been assessed and accounted for in accordnance with the requirements of IFRS 9 as a modification of loan arrangement.

Accounting for zero rate repo facilities $(d)$

The QCB has advised banks to extend new financing to affected sectors at reduced rates, which is to be supported by zero-cost repo facilities from QCB, and extended guarantees from the government of the State of Qatar to local banks to support these affected sectors. The benefit arising out of the zero rate repos was not considered to be material for the period.

21. Comparative information

Certain comparative information has been reclassified where necessary to preserve consistency with the presentation in the current period. However, such reclassifications did not have any effect on the interim consolidated statement of income or the consolidated equity of the Group for the comparative period / year.